Unbound MEDLINE

Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias. Acta oncologica (Stockholm, Sweden) [Acta Oncol] Journal article

 
TitleConcomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
Author(s)Stagno F, Vigneri P, Fabro VD, Stella S, Restuccia N, Giallongo C, Massimino M, Berretta S, Pennisi MS, Tibullo D, Tirrò E, Buscarino C, Messina A, Raimondo FD 
InstitutionDepartment of Biomedical Sciences, Section of Hematology, University of Catania, Italy.
SourceActa Oncol 2009 Oct 20.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19842797
  
Advertise on this site.